World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2020-10-01
|
| Series: | Global Medical Genetics |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1721451 |